Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients? A systematic review and meta-analysis.

Dabir PD, Bruggeling CE, van der Post RS, Dutilh BE, Hoogerbrugge N, Ligtenberg MJL, Boleij A, Nagtegaal ID.

Eur J Hum Genet. 2019 Nov 6. doi: 10.1038/s41431-019-0538-7. [Epub ahead of print] Review.

PMID:
31695176
2.

Synoptic reporting increases quality of upper gastrointestinal cancer pathology reports.

Baranov NS, Nagtegaal ID, van Grieken NCT, Verhoeven RHA, Voorham QJM, Rosman C, van der Post RS.

Virchows Arch. 2019 Aug;475(2):255-259. doi: 10.1007/s00428-019-02586-w. Epub 2019 May 29.

3.

Colorectal metastasis to the gallbladder mimicking a primary gallbladder malignancy: histopathological and molecular characteristics.

de Bitter TJJ, van der Linden RLA, van Vliet S, Weren F, Sie D, Ylstra B, van der Linden HC, Knijn N, Ligtenberg MJL, van der Post RS, Simmer F, Nagtegaal ID.

Histopathology. 2019 Sep;75(3):394-404. doi: 10.1111/his.13892. Epub 2019 Jul 18.

4.

Hereditary gastric cancer: what's new? Update 2013-2018.

van der Post RS, Oliveira C, Guilford P, Carneiro F.

Fam Cancer. 2019 Jul;18(3):363-367. doi: 10.1007/s10689-019-00127-7. Review.

PMID:
30989426
5.

Correction to: Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.

Mariette C, Carneiro F, Grabsch HI, van der Post RS, Allum W, de Manzoni G; European Chapter of International Gastric Cancer Association.

Gastric Cancer. 2019 Mar;22(2):421. doi: 10.1007/s10120-019-00925-z.

PMID:
30631987
6.

Tumour deposits are a significant prognostic factor in gastric cancer - a systematic review and meta-analysis.

Graham Martínez C, Knijn N, Verheij M, Nagtegaal ID, van der Post RS.

Histopathology. 2019 May;74(6):809-816. doi: 10.1111/his.13781. Epub 2019 Feb 10.

7.

Incidence of Progression of Persistent Nondysplastic Barrett's Esophagus to Malignancy.

Peters Y, Honing J, Kievit W, Kestens C, Pestman W, Nagtegaal ID, van der Post RS, Siersema PD.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):869-877.e5. doi: 10.1016/j.cgh.2018.08.033. Epub 2018 Sep 11.

PMID:
30213587
8.

Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.

Mariette C, Carneiro F, Grabsch HI, van der Post RS, Allum W, de Manzoni G; European Chapter of International Gastric Cancer Association.

Gastric Cancer. 2019 Jan;22(1):1-9. doi: 10.1007/s10120-018-0868-0. Epub 2018 Aug 25. Erratum in: Gastric Cancer. 2019 Jan 10;:.

9.

Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility.

Weren RDA, van der Post RS, Vogelaar IP, van Krieken JH, Spruijt L, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Oliveira C, Kamping EJ, Schackert HK, Ranzani GN, Gómez García EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Cats A, Bjørnevoll I, Hoogerbrugge N, Ligtenberg MJL.

J Med Genet. 2018 Oct;55(10):669-674. doi: 10.1136/jmedgenet-2017-104962. Epub 2018 Jan 12.

10.

Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders.

van der Post RS, Carneiro F.

Surg Pathol Clin. 2017 Dec;10(4):931-945. doi: 10.1016/j.path.2017.07.011. Review.

PMID:
29103540
11.

Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing.

Vogelaar IP, van der Post RS, van Krieken JHJ, Spruijt L, van Zelst-Stams WA, Kets CM, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Pinheiro H, Oliveira C, Jhangiani SN, Muzny DM, Gibbs RA, Lupski JR, de Ligt J, Vissers LELM, Hoischen A, Gilissen C, van de Vorst M, Goeman JJ, Schackert HK, Ranzani GN, Molinaro V, Gómez García EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Bjørnevoll I, Høberg-Vetti H, van Kessel AG, Kuiper RP, Ligtenberg MJL, Hoogerbrugge N.

Eur J Hum Genet. 2017 Nov;25(11):1246-1252. doi: 10.1038/ejhg.2017.138. Epub 2017 Sep 6.

12.

Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.

van der Post RS, van Dieren J, Grelack A, Hoogerbrugge N, van der Kolk LE, Snaebjornsson P, Lansdorp-Vogelaar I, van Krieken JH, Bisseling TM, Cats A.

Gastrointest Endosc. 2018 Feb;87(2):397-404.e2. doi: 10.1016/j.gie.2017.04.016. Epub 2017 Apr 25.

PMID:
28455161
13.

Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease.

Nissen LH, Assendorp EL, van der Post RS, Derikx LA, de Jong DJ, Kievit W, Pierik M, van den Heuvel T, Verhoeven R, Overbeek LI, Hoentjen F, Nagtegaal ID.

J Gastrointestin Liver Dis. 2016 Dec;25(4):431-440. doi: 10.15403/jgld.2014.1121.254.nis.

14.

Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.

van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch HI, O'Donovan M, Fitzgerald RC, van Krieken H, Carneiro F.

Adv Exp Med Biol. 2016;908:E1. No abstract available.

PMID:
27778307
15.

Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.

van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch HI, O'Donovan M, Fitzgerald RC, van Krieken H, Carneiro F.

Adv Exp Med Biol. 2016;908:371-91. doi: 10.1007/978-3-319-41388-4_18. Review. Erratum in: Adv Exp Med Biol. 2016;908:E1.

PMID:
27573781
16.

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect.

Vogelaar IP, Ligtenberg MJ, van der Post RS, de Voer RM, Kets CM, Jansen TJ, Jacobs L, Schreibelt G; International Gastric Cancer Genetics Group, de Vries IJ, Netea MG, Hoogerbrugge N.

Fam Cancer. 2016 Apr;15(2):289-96. doi: 10.1007/s10689-015-9859-z.

17.

Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.

van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ.

Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.

PMID:
26072394
18.

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC.

J Med Genet. 2015 Jun;52(6):361-74. doi: 10.1136/jmedgenet-2015-103094. Epub 2015 May 15. Review.

19.

Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer.

Dienstmann R, Patnaik A, Garcia-Carbonero R, Cervantes A, Benavent M, Roselló S, Tops BB, van der Post RS, Argilés G, Skartved NJ, Hansen UH, Hald R, Pedersen MW, Kragh M, Horak ID, Braun S, Van Cutsem E, Tolcher AW, Tabernero J.

Cancer Discov. 2015 Jun;5(6):598-609. doi: 10.1158/2159-8290.CD-14-1432. Epub 2015 May 11.

20.

The molecular background of mucinous carcinoma beyond MUC2.

Hugen N, Simons M, Halilović A, van der Post RS, Bogers AJ, Marijnissen-van Zanten MA, de Wilt JH, Nagtegaal ID.

J Pathol Clin Res. 2014 Nov 5;1(1):3-17. doi: 10.1002/cjp2.1. eCollection 2015 Jan. Review.

21.

Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation.

Vogelaar IP, van der Post RS, van de Vosse E, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ, Gómez García E.

Fam Cancer. 2015 Mar;14(1):89-94. doi: 10.1007/s10689-014-9764-x.

PMID:
25467645
22.

HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma.

van der Post RS, Bult P, Vogelaar IP, Ligtenberg MJ, Hoogerbrugge N, van Krieken JH.

Virchows Arch. 2014 Jun;464(6):673-9. doi: 10.1007/s00428-014-1574-x. Epub 2014 Apr 8.

PMID:
24711169
23.

Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma.

Boesaard EP, Vogelaar IP, Bult P, Wauters CA, van Krieken JH, Ligtenberg MJ, van der Post RS, Hoogerbrugge N.

Hered Cancer Clin Pract. 2014 Dec 12;12(1):21. doi: 10.1186/1897-4287-12-21. eCollection 2014.

24.

A patient with pure red cell aplasia after allogenic stem-cell transplantation. Parvo B19 infection.

Berrevoets MA, van der Post RS, Schaap N.

Neth J Med. 2013 Sep;71(7):370, 374. No abstract available.

25.

The evaluation of colon biopsies using virtual microscopy is reliable.

van der Post RS, van der Laak JA, Sturm B, Clarijs R, Schaafsma HE, van Krieken JH, Nap M.

Histopathology. 2013 Jul;63(1):114-21. doi: 10.1111/his.12131. Epub 2013 May 21.

PMID:
23692065
26.

Familial gastric cancer: detection of a hereditary cause helps to understand its etiology.

Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JHJ, Ligtenberg MJ, Hoogerbrugge N.

Hered Cancer Clin Pract. 2012 Dec 12;10(1):18. doi: 10.1186/1897-4287-10-18.

27.

Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts.

Vogelaar IP, Figueiredo J, van Rooij IA, Simões-Correia J, van der Post RS, Melo S, Seruca R, Carels CE, Ligtenberg MJ, Hoogerbrugge N.

Hum Mol Genet. 2013 Mar 1;22(5):919-26. doi: 10.1093/hmg/dds497. Epub 2012 Nov 29.

PMID:
23197654
28.

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.

Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ET, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FB, Leter EM, Gille JJ, Aalfs CM, Redeker EJ, Hes FJ, Tops CM, van Nesselrooij BP, van Gijn ME, Gómez García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, Oláh E, Chan TL, Leung SY, van Kessel AG, Kiemeney LA, Hoogerbrugge N, Ligtenberg MJ.

Lancet Oncol. 2011 Jan;12(1):49-55. doi: 10.1016/S1470-2045(10)70265-5. Epub 2010 Dec 8.

29.

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.

van der Post RS, Kiemeney LA, Ligtenberg MJ, Witjes JA, Hulsbergen-van de Kaa CA, Bodmer D, Schaap L, Kets CM, van Krieken JH, Hoogerbrugge N.

J Med Genet. 2010 Jul;47(7):464-70. doi: 10.1136/jmg.2010.076992.

30.

Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis.

van der Post RS, Kets CM, Ligtenberg MJ, van Krieken JH, Hoogerbrugge N.

Virchows Arch. 2009 Jan;454(1):25-9. doi: 10.1007/s00428-008-0701-y. Epub 2008 Nov 25.

PMID:
19031083

Supplemental Content

Loading ...
Support Center